Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases
Exploration of Digestive Diseases · 10.12.2024 · 3 (6) · 474-503
DOI: 10.37349/edd.2024.00062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration of Digestive Diseases, online erschienen am 10.12.2024. Verfasst von Hala Saeed Jaara und 1 weiteren Autor:innen. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 223 Literaturangaben. Gefördert von: Agència de Gestió d'Ajuts Universitaris i de Recerca.
Abstract (Originalsprache)
Mitochondria are essential organelles responsible for intracellular energy production and play crucial roles in cellular metabolism, inflammation, and apoptosis. Reactive oxygen species (ROS) are primarily produced in the mitochondria and endoplasmic reticulum of hepatocytes due to the activity of cytochrome P450 enzymes. Under ideal conditions, cells have specific molecular mechanisms that manage oxidative stress levels, thus ensuring a balance between oxidants and antioxidants. The interplay between ROS-induced mitochondrial dysfunction and the activation of the NLRP3 (nucleotide-binding oligomerization domain-like receptor family, pyrin domain containing 3) inflammasome in the context of liver diseases has been extensively studied. However, the exact mechanisms by which mitochondria promote the activation of the NLRP3 inflammasome and contribute to the onset of liver disease remain unclear. This review aims to elucidate the recently discovered mitochondrial regulation of the NLRP3 inflammasome in liver disorders, including alcohol-related liver disease (ALD), metabolic-associated steatotic liver disease (MASLD), and hepatocellular carcinoma (HCC). Finally, it summarizes various natural and pharmaceutical agents that can mitigate liver damage by modulating the activation of the NLRP3 inflammasome through mitochondrial pathways. This work serves as an important resource for identifying new therapeutic approaches and provides further support for advancing the understanding of liver diseases.
Förderung
- Agència de Gestió d'Ajuts Universitaris i de Recerca
Zitieren
APA
Jaara, H. S., & Torres, S. (2024). Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases. Exploration of Digestive Diseases, 3(6), 474-503. https://doi.org/10.37349/edd.2024.00062
Vancouver
Jaara HS, Torres S. Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases. Exploration of Digestive Diseases. 2024;3(6):474-503. doi:10.37349/edd.2024.00062
BibTeX
@article{Jaara2024,
author = {Jaara, Hala Saeed and Torres, Sandra},
title = {Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases},
journal = {Exploration of Digestive Diseases},
year = {2024},
volume = {3},
number = {6},
pages = {474--503},
doi = {10.37349/edd.2024.00062}
}
EUVIMED